Matches in SemOpenAlex for { <https://semopenalex.org/work/W2767769087> ?p ?o ?g. }
- W2767769087 endingPage "106806" @default.
- W2767769087 startingPage "106790" @default.
- W2767769087 abstract "// Qingxi Qu 1 , Weidong Bing 1 , Xiangbin Meng 1 , Jie Xi 1 , Xiao Bai 1 , Qing Liu 2 , Yaqiu Guo 3 , Xin Zhao 1 and Yanwen Bi 1 1 Department of Cardiovascular Surgery, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China 2 Department of Ultrasound, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250012, China 3 Department of Anesthesiology, Jinan Maternity and Child Health Care Hospital, Jinan, Shandong 250012, China Correspondence to: Yanwen Bi, email: yanwenbi11@126.com.cn Keywords: miRNAs, human saphenous vein, vein graft, endothelial cells, neointimal formation Received: June 30, 2017 Accepted: August 27, 2017 Published: November 03, 2017 ABSTRACT Poor long-term patency of vein grafts remains an obstacle in coronary artery bypass grafting (CABG) surgery using an autologous saphenous vein graft. Recent studies have revealed that miR-126-3p promotes vascular integrity and angiogenesis. We aimed to identify the role of miR-126-3p in the setting of vein graft disease and investigate the value of miR-126-3p agomir as a future gene therapy in vein graft failure. Expression analysis of circulating miR-126-3p in plasma from CABG patients established the basic clues that miR-126-3p participates in CABG. The in vitro results indicated that elevated miR-126-3p expression significantly improved proliferation and migration in human saphenous vein endothelial cells (HSVECs) by targeting sprouty-related protein-1 (SPRED-1) and phosphatidylinositol-3-kinase regulatory subunit 2 (PIK3R2), but not in human saphenous vein smooth muscle cells (HSVSMCs). Moreover, the therapeutic potential of miR-126-3p agomir was demonstrated in cultured human saphenous vein (HSV) ex vivo . Finally, local delivery of miR-126-3p agomir was confirmed to enhance reendothelialization and attenuate neointimal formation in a rat vein arterialization model. In conclusion, we provide evidence that upregulation of miR-126-3p by agomir possesses potential clinical value in the prevention and treatment of autologous vein graft restenosis in CABG." @default.
- W2767769087 created "2017-11-17" @default.
- W2767769087 creator A5017941291 @default.
- W2767769087 creator A5031240287 @default.
- W2767769087 creator A5040245929 @default.
- W2767769087 creator A5058197133 @default.
- W2767769087 creator A5063925099 @default.
- W2767769087 creator A5073525543 @default.
- W2767769087 creator A5078094042 @default.
- W2767769087 creator A5078936866 @default.
- W2767769087 creator A5083333991 @default.
- W2767769087 date "2017-11-03" @default.
- W2767769087 modified "2023-10-16" @default.
- W2767769087 title "Upregulation of miR-126-3p promotes human saphenous vein endothelial cell proliferation <i>in vitro</i> and prevents vein graft neointimal formation <i>ex vivo</i> and <i>in vivo</i>" @default.
- W2767769087 cites W144423133 @default.
- W2767769087 cites W1506285471 @default.
- W2767769087 cites W1595524810 @default.
- W2767769087 cites W1800547622 @default.
- W2767769087 cites W1945493095 @default.
- W2767769087 cites W1965379944 @default.
- W2767769087 cites W1967265610 @default.
- W2767769087 cites W1978460527 @default.
- W2767769087 cites W1979522967 @default.
- W2767769087 cites W1980888291 @default.
- W2767769087 cites W1988163167 @default.
- W2767769087 cites W1988194907 @default.
- W2767769087 cites W1997459399 @default.
- W2767769087 cites W2000825997 @default.
- W2767769087 cites W2013322344 @default.
- W2767769087 cites W2015086840 @default.
- W2767769087 cites W2021090126 @default.
- W2767769087 cites W2026099724 @default.
- W2767769087 cites W2027984042 @default.
- W2767769087 cites W2039551908 @default.
- W2767769087 cites W2043469561 @default.
- W2767769087 cites W2044991253 @default.
- W2767769087 cites W2064242341 @default.
- W2767769087 cites W2065025152 @default.
- W2767769087 cites W2072190764 @default.
- W2767769087 cites W2077188557 @default.
- W2767769087 cites W2077844301 @default.
- W2767769087 cites W2086282268 @default.
- W2767769087 cites W2095403246 @default.
- W2767769087 cites W2108661174 @default.
- W2767769087 cites W2109341154 @default.
- W2767769087 cites W2109537977 @default.
- W2767769087 cites W2110973939 @default.
- W2767769087 cites W2115277186 @default.
- W2767769087 cites W2126336279 @default.
- W2767769087 cites W2129994868 @default.
- W2767769087 cites W2130290719 @default.
- W2767769087 cites W2149692562 @default.
- W2767769087 cites W2157916750 @default.
- W2767769087 cites W2163054103 @default.
- W2767769087 cites W2163181184 @default.
- W2767769087 cites W2163294226 @default.
- W2767769087 cites W2167073180 @default.
- W2767769087 cites W2167323664 @default.
- W2767769087 cites W2170317293 @default.
- W2767769087 cites W2224887882 @default.
- W2767769087 cites W2239721108 @default.
- W2767769087 cites W2259095267 @default.
- W2767769087 cites W2269676560 @default.
- W2767769087 cites W2323508272 @default.
- W2767769087 cites W2396077428 @default.
- W2767769087 cites W2486397717 @default.
- W2767769087 cites W2580225965 @default.
- W2767769087 cites W2592391558 @default.
- W2767769087 cites W2616651817 @default.
- W2767769087 cites W4253138683 @default.
- W2767769087 doi "https://doi.org/10.18632/oncotarget.22365" @default.
- W2767769087 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5739774" @default.
- W2767769087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29290989" @default.
- W2767769087 hasPublicationYear "2017" @default.
- W2767769087 type Work @default.
- W2767769087 sameAs 2767769087 @default.
- W2767769087 citedByCount "20" @default.
- W2767769087 countsByYear W27677690872019 @default.
- W2767769087 countsByYear W27677690872020 @default.
- W2767769087 countsByYear W27677690872021 @default.
- W2767769087 countsByYear W27677690872022 @default.
- W2767769087 countsByYear W27677690872023 @default.
- W2767769087 crossrefType "journal-article" @default.
- W2767769087 hasAuthorship W2767769087A5017941291 @default.
- W2767769087 hasAuthorship W2767769087A5031240287 @default.
- W2767769087 hasAuthorship W2767769087A5040245929 @default.
- W2767769087 hasAuthorship W2767769087A5058197133 @default.
- W2767769087 hasAuthorship W2767769087A5063925099 @default.
- W2767769087 hasAuthorship W2767769087A5073525543 @default.
- W2767769087 hasAuthorship W2767769087A5078094042 @default.
- W2767769087 hasAuthorship W2767769087A5078936866 @default.
- W2767769087 hasAuthorship W2767769087A5083333991 @default.
- W2767769087 hasBestOaLocation W27677690871 @default.
- W2767769087 hasConcept C104317684 @default.
- W2767769087 hasConcept C126322002 @default.
- W2767769087 hasConcept C127561419 @default.
- W2767769087 hasConcept C141071460 @default.
- W2767769087 hasConcept C150903083 @default.